Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Bone Marrow Transplantation

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    March 2018
  1. GASSAS A, Sivaprakasam P, Cummins M, Breslin P, et al
    High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0157.
    PubMed     Text format     Abstract available


    January 2018
  2. SAITO H, Ito M, Kato S, Kodera Y, et al
    The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0084.
    PubMed     Text format     Abstract available


  3. GAUTHIER J, Poire X, Gac AC, Leclerc M, et al
    Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0018.
    PubMed     Text format     Abstract available


  4. FERNANDES JF, Bonfim C, Kerbauy FR, Rodrigues M, et al
    Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0015.
    PubMed     Text format     Abstract available


  5. DEVILLIER R, Labopin M, Chevallier P, Ledoux MP, et al
    Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Ma
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0043.
    PubMed     Text format     Abstract available


    September 2017
  6. SUGIYAMA M, Iguchi A, Yamada M, Terashita Y, et al
    Successful bone marrow transplantation in two sisters with activated phosphoinositide 3-kinase delta syndrome 2.
    Bone Marrow Transplant. 2017 Sep 4. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    July 2017
  7. KAWAMURA K, Kanda J, Fuji S, Murata M, et al
    Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2017 Jul 17. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  8. BACHEGOWDA LS, Shah MV, Veltri LW, Tanase A, et al
    HLA-mismatched bone marrow transplantation in severe aplastic anemia.
    Bone Marrow Transplant. 2017 Jul 10. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    April 2017
  9. DVORAK CC, Patel K, Puck JM, Wahlstrom J, et al
    Unconditioned unrelated donor bone marrow transplantation for IL7Ralpha- and Artemis-deficient SCID.
    Bone Marrow Transplant. 2017 Apr 24. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    March 2017
  10. HO C, Zacharin M
    Fertility preservation in an adolescent boy: inducing puberty and spermatogenesis prior to elective, non-urgent bone marrow transplantation.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    January 2017
  11. GAUTHIER J, Castagna L, Garnier F, Guillaume T, et al
    Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  12. GOYAL RK, Lee SJ, Wang T, Trucco M, et al
    Novel HLA-DP region susceptibility loci associated with severe acute GvHD.
    Bone Marrow Transplant. 2017;52:95-100.
    PubMed     Text format     Abstract available


  13. ZHENG CC, Zhu XY, Tang BL, Zhang XH, et al
    Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML.
    Bone Marrow Transplant. 2017;52:88-94.
    PubMed     Text format     Abstract available


    November 2016
  14. FIFE BL, Von Ah DM, Spath ML, Weaver MT, et al
    Preliminary efficacy of a brief family intervention to prevent declining quality of life secondary to parental bone marrow transplantation.
    Bone Marrow Transplant. 2016 Nov 21. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    September 2016
  15. GHAVAMZADEH A, Alimoghaddam K, Jalili M, Mousavi SA, et al
    Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  16. ARAI Y, Kondo T, Shigematsu A, Tanaka J, et al
    High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    August 2016
  17. O'DONNELL PV, Eapen M, Horowitz MM, Logan BR, et al
    Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  18. GALLO S, Woolfrey AE, Burroughs LM, Storer BE, et al
    Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?
    Bone Marrow Transplant. 2016 Aug 1. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    July 2016
  19. CAGDAS D, Erman B, Hanoglu D, Tavil B, et al
    Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other.
    Bone Marrow Transplant. 2016 Jul 25. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  20. ZAMPAOLO AS, Kanold J, Tournilhac O, Franck F, et al
    Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantation.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  21. GALE RP
    Thirty years of Bone Marrow Transplantation.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    April 2016
  22. STAMATOULLAS A, Brice P, Gueye MS, Mareschal S, et al
    Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC).
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  23. PIETZNER J, Merscher BM, Baer PC, Duecker RP, et al
    Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.
    Bone Marrow Transplant. 2016;51:619.
    PubMed     Text format    


  24. YABE H, Morimoto T, Takakura H, Okuya M, et al
    Post-transplantation-emerging anti-HLA DQA1/DQB1 antibody possibly responsible for graft rejection after myeloablative-unrelated marrow grafting.
    Bone Marrow Transplant. 2016;51:601-3.
    PubMed     Text format    


    March 2016
  25. OBUT F, Kasinath V, Abdi R
    Post-bone marrow transplant thrombotic microangiopathy.
    Bone Marrow Transplant. 2016 Mar 14. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  26. SORENSEN BS, Szer J, Shaw B, Korhonen M, et al
    Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned.
    Bone Marrow Transplant. 2016 Mar 14. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    February 2016
  27. CUPIT MC, Duncan C, Savani BN, Hashmi SK, et al
    Childhood to adult transition and long-term follow-up after blood and marrow transplantation.
    Bone Marrow Transplant. 2016;51:176-81.
    PubMed     Text format     Abstract available


    January 2016
  28. MIZUTANI M, Hara M, Fujita H, Aoki J, et al
    Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR.
    Bone Marrow Transplant. 2016 Jan 25. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  29. PIETZNER J, Merscher BM, Baer PC, Duecker RP, et al
    Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  30. BARONCIANI D, Angelucci E, Potschger U, Gaziev J, et al
    Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  31. NICKEL RS, Waller EK, Qayed M, Chiang KY, et al
    Clinically significant adverse events after major ABO mismatch BMT.
    Bone Marrow Transplant. 2016;51:148-9.
    PubMed     Text format    


    November 2015
  32. FUJI S, Kim SW, Yano S, Hagiwara S, et al
    A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F.
    Bone Marrow Transplant. 2015 Nov 9. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  33. HAJI S, Kiyasu J, Choi I, Suehiro Y, et al
    Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma.
    Bone Marrow Transplant. 2015 Nov 2. doi: 10.1038/bmt.2015.
    PubMed     Text format    


    October 2015
  34. PAGLIUCA S, Gerard L, Kulasekararaj A, Eapen M, et al
    Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation.
    Bone Marrow Transplant. 2015 Oct 19. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  35. KANDA Y, Kobayashi T, Mori T, Tanaka M, et al
    A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2015 Oct 5. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


    September 2015
  36. CHANTEPIE SP, Michallet M, Blaise D, Maury S, et al
    Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Bone Marrow Transplant. 2015 Sep 14. doi: 10.1038/bmt.2015.
    PubMed     Text format    


    June 2015
  37. BACIGALUPO A, Dominietto A, Ghiso A, Di Grazia C, et al
    Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update.
    Bone Marrow Transplant. 2015;50 Suppl 2:S37-9.
    PubMed     Text format     Abstract available


  38. ARCESE W, Picardi A, Santarone S, De Angelis G, et al
    Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update.
    Bone Marrow Transplant. 2015;50 Suppl 2:S24-30.
    PubMed     Text format     Abstract available


  39. SYKES M
    Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation.
    Bone Marrow Transplant. 2015;50 Suppl 2:S82-6.
    PubMed     Text format     Abstract available


  40. FUCHS EJ
    HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide.
    Bone Marrow Transplant. 2015;50 Suppl 2:S31-6.
    PubMed     Text format     Abstract available


  41. CHANG YJ, Huang XJ
    Improving the clinical outcome of unmanipulated haploidentical blood and marrow transplantation.
    Bone Marrow Transplant. 2015;50 Suppl 2:S21-3.
    PubMed     Text format     Abstract available


  42. LEFFELL MS, Jones RJ, Gladstone DE
    Donor HLA-specific Abs: to BMT or not to BMT?
    Bone Marrow Transplant. 2015;50:751-8.
    PubMed     Text format     Abstract available


    May 2015
  43. RUIZ-ARGUELLES GJ, Abello-Polo V, Arrais-Rodrigues C, Bouzas LF, et al
    Publications of bone marrow transplants in Latin America. A report of the Latin American Group of Bone Marrow Transplantation.
    Bone Marrow Transplant. 2015 May 11. doi: 10.1038/bmt.2015.
    PubMed     Text format    


    April 2015
  44. PATRICK K, Lau W, Gassas A, McDougall E, et al
    Major ABO incompatible BMT in children: determining what residual volume of donor red cells can safely be infused following red cell depletion.
    Bone Marrow Transplant. 2015;50:536-9.
    PubMed     Text format     Abstract available


    March 2015
  45. ESTEVES I, Bonfim C, Pasquini R, Funke V, et al
    Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.
    Bone Marrow Transplant. 2015 Mar 2. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


    February 2015
  46. ROBERTO A, Castagna L, Gandolfi S, Zanon V, et al
    B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY.
    Bone Marrow Transplant. 2015;50:317-9.
    PubMed     Text format    


  47. TANG BL, Zhu XY, Zheng CC, Liu HL, et al
    Successful early unmanipulated haploidentical transplantation with reduced-intensity conditioning for primary graft failure after cord blood transplantation in hematologic malignancy patients.
    Bone Marrow Transplant. 2015;50:248-52.
    PubMed     Text format     Abstract available


    January 2015
  48. TAVERNIER E, Desnos-Ollivier M, Honeyman F, Srour M, et al
    Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit.
    Bone Marrow Transplant. 2015;50:158-60.
    PubMed     Text format    


  49. GHISO A, Raiola AM, Gualandi F, Dominietto A, et al
    DLI after haploidentical BMT with post-transplant CY.
    Bone Marrow Transplant. 2015;50:56-61.
    PubMed     Text format     Abstract available


    November 2014
  50. HENGEVELD M, Suciu S, Chelgoum Y, Marie JP, et al
    High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.
    Bone Marrow Transplant. 2014 Nov 17. doi: 10.1038/bmt.2014.
    PubMed     Text format     Abstract available


    September 2014
  51. GOMEZ E, Dulery R, Langlois C, Coiteux V, et al
    Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimen.
    Bone Marrow Transplant. 2014 Sep 15. doi: 10.1038/bmt.2014.
    PubMed     Text format     Abstract available


    June 2014
  52. BIGLIARDI S, Morselli M, Potenza L, Bresciani P, et al
    An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells?
    Bone Marrow Transplant. 2014 Jun 2. doi: 10.1038/bmt.2014.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Bone Marrow Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: